p. Provisions, contingent liabilities, and contingent assets
Provisions are recognized for liabilities that can be measured only by using a substantial degree of estimation, if:
I) the Company has a present obligation as a result of a past event;
II) a probable outflow of resources is expected to settle the obligation; and
III) the amount of the obligation can be reliably estimated.
Provision is measured using the cash flows estimated to settle the present obligation and when the effect of time value of money is material, the carrying amount of the provision is the present value of those cash flow. Reimbursement expected in respect of expenditure required to settle a provision is recognized only when it is virtually certain that the reimbursement will be received and a reliable estimate can be made of the amount of the obligation.
Provisions for onerous contracts are recognized when the expected benefits to be derived by the Company from a contract are lower than the unavoidable costs of meeting the future obligations under the contract. Provisions for onerous contracts are measured at the present value of lower of the expected net cost of fulfilling the contract and the expected cost of terminating the contract.
Contingent liability is disclosed in case of,
I) a present obligation arising from a past event when it is not probable that an outflow of resources will be required to settle the obligation or the amount of obligation cannot be measured with sufficient reliability; or
II) a possible obligation arising from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity.
Contingent assets are neither recognized nor disclosed.
Provisions, contingent liabilities, and contingent assets are reviewed at each balance sheet date.
q. Earnings per share
Basic earnings per share is computed by dividing the net profit after tax by the weighted average number of equity shares outstanding during the year, adjusted for treasury shares held and bonus elements in equity shares issued during the year.
Diluted EPS is computed by dividing the net profit after tax by the weighted average number of equity shares considered for deriving basic EPS and also weighted average number of equity shares that could have been issued upon conversion of all dilutive potential equity shares. Dilutive potential equity shares are deemed converted as of the beginning of the year, unless issued at a later date. Dilutive potential equity shares are determined independently for each period presented.
r. Statement of Cash flows
Statement of Cash flows is prepared segregating the cash flows from operating, investing and financing activities. Statement of Cash flows is reported using indirect method, whereby profit for the year is adjusted for the effects of transactions of a non cash nature, any deferrals or accruals of past or future operating cash receipts or payments and item of income or expenses associated with investing or financing cash flows.
s. Business Combination
Business combinations other than the common control transactions are accounted for applying the acquisition method. The purchase price is measured as the fair value of the assets transferred, equity instruments issued and liabilities incurred or assumed at the date of obtaining control. The cost of acquisition also includes the fair value of any contingent consideration. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair value on the date of acquisition. The contingent consideration is measured at fair value at each reporting date.
Transaction costs incurred in connection with a business acquisition are expensed as incurred. Any subsequent changes to the fair value of contingent consideration classified as liabilities, other than measurement period adjustments, are recognized in the statement of profit and loss.
Goodwill represents the cost of the acquired businesses in excess of the fair value of identifiable tangible and intangible net assets purchased.
Business combinations through common control transactions are accounted on a pooling of interest method. No adjustments are made to reflect the fair values, or recognise any new assets or liabilities, except to harmonise accounting policies. The identity of the reserves are preserved and the reserves of the transferor becomes the reserves of the transferee. The difference between consideration paid and the net assets acquired, if any, is recorded under capital reserve/retained earnings, as applicable.
t. Recent accounting pronouncement
The Ministry of Corporate Affairs (“MCA”) notifies new standards or amendments to the existing standards under Companies (Indian Accounting Standards) Rules, as issued from time to time.
In May 2025, MCA notified amendments to Ind AS 21 - The Effects of Changes in Foreign Exchange Rates, applicable w.e.f. April 1,2025. The Company has reviewed the amendment and, based on its evaluation, has determined that it does not have any significant impact on its financial statements.
In August 2025, MCA notified the following amendments:
i) Ind AS 1 - Presentation of Financial Statements, applicable w.e.f. April 1, 2025
The amendment relates to classification of liabilities as current or non-current and non-current liabilities with covenants. In the context of classifying a liability as current, it removes the requirement of existence of a right to defer settlement for at least 12 months after the reporting date, and instead requires that the said right should exist on the reporting date and have substance. The amendment also introduces guidance on classification of liabilities with covenants. The Company has no impact of these amendments in its classification criteria of current and non¬ current liabilities.
ii) Ind AS 7 - Statement of Cash Flows and Ind AS 107 - Financial Instruments: Disclosures, applicable w.e.f. April 1, 2025
The amendment in Ind AS 7 requires entities to inform users of financial statements of the existence of supplier finance arrangements and explain the nature of the arrangements, the carrying amount of liabilities and the range of payment due dates. Ind AS 107 has been amended to add supplier finance arrangements as a factor that may cause concentration of liquidity risk. The Company has reviewed the amendment and, based on its evaluation, it has made appropriate disclosures in the standalone financial statements.
iii) Ind AS 12 - International Tax Reform - Pillar Two Model Rules apply immediately
The amendments provide a temporary mandatory relief from deferred tax accounting for top-up tax and disclose that they have applied the relief. This relief is immediate and applies retrospectively and there is no material financial impact due to application of the Pillar two rules.
For the purpose of impairment testing, goodwill acquired in a business combination is allocated to the Cash Generating Units (CGU) or groups of CGUs, which benefit from the synergies of the acquisition.
The recoverable amount of a CGU is determined based on value-in-use. Value-in-use is present value of future cash flows expected to be derived from the CGU. The growth rate for forecast period of 5 years is based on historical trend and an appropriate annual growth rate of 2% is considered for periods subsequent to the forecast period. The pre-tax discount rate ranges from 16.5% to 16.8% based on Weighted Average Cost of Capital for the Company.
The Company does its impairment evaluation on an annual basis and based on such evaluation the estimated recoverable amount of the CGU exceeded its carrying amount, hence impairment is not triggered as at reporting date. The Company has performed sensitivity analysis for all key assumptions, including the cash flow projections and is unlikely to cause the carrying amount of the CGU exceed its estimated recoverable amount. These estimates are likely to differ from future actual results of operations and cash flows.
(a) Employee Stock Option Scheme 2015 ('ESOP Scheme - 2015')
Shares under this program are granted to employees at an exercise price of not less than I 1 per equity share or such higher price as determined by the Board but shall not exceed the market price as defined in the Regulations. Shares shall vest over such term as determined by the Nomination and Remuneration Committee not exceeding five years from the date of the grant. These options are exercisable within 7 years from the date of grant.
(b) Employee Stock Option Plan 2021 ('ESOP 2021')
On May 22, 2021, the shareholders of the Company have approved the Employee Stock Option Plan 2021 (‘ESOP 2021’) for the issue of upto 2,000,000 options to employees of the Company.
The Nomination and Remuneration Committee ('NRC') shall determine the exercise price which will not be less than the face value of the shares. Options under this program are granted to employees at an exercise price periodically determined by the NRC. All stock options have a four-year vesting term. These options are exercisable within 6 years from the date of vesting.
(b) Employee Stock Option Plan 2021 ('ESOP 2021') - Series A and Series B
During the year ended March 31,2026 and March 31,2025, no new grants have been issued.
IX) The aggregate number of equity shares allotted as fully paid up by way of bonus shares in immediately preceding five years ended March 31,2026 is Nil.
X) An aggregate of 120,397,266 equity shares of I 1 each were issued on November 25, 2022 pursuant to amalgamation with erstwhile Mindtree Limited, without payment being received in cash in immediately preceding five years ended March 31,2026.
XI) The aggregate number of equity shares bought back in immediately preceding five years ended March 31,2026 is Nil.
Notes:
1. Capital reserve on business combination represents the gains of capital nature which mainly include the excess of value of net assets acquired over consideration paid by the Company for business amalgamation transactions in earlier years. It also represents capital reserve on business combination which arises on transfer of business between entities under common control.
2. It represents a sum equal to the nominal value of the share capital extinguished on buy-back of Company's own shares pursuant to Section 69 of the Companies Act, 2013.
3. Securities premium includes:
(a) The difference between the face value of the equity shares and the consideration received in respect of shares issued;
(b) The fair value of the stock options which are treated as expense, if any, in respect of shares allotted pursuant to Stock Options Scheme.
(c) Incremental directly attributable costs incurred in issuing or acquiring an entity's own equity instruments.
4. The Company created a General reserve in earlier years pursuant to the provisions of the Companies Act, 1956 where in certain percentage of profits was required to be transferred to General reserve before declaring dividends. As per Companies Act, 2013, the requirements to transfer profits to General reserve is not mandatory. General reserve is a free reserve available to the Company.
5. It represents the fair value of services received against employees stock options.
6. The hedging reserve represents the cumulative effective portion of gains or losses arising on changes in fair value of designated portion of hedging instruments entered into for cash flow hedges. Such gains or losses will be reclassified to Statement of profit and loss in the period in which the hedged transaction occurs.
7. Retained earnings represents the undistributed profits of the Company accumulated as on Balance Sheet date.
‘Includes disputed dues provided pursuant to unfavorable orders received from the tax authorities as at March 31, 2026 I 119 (As at March 31, 2025: I 116) against which the Company has preferred an appeal with the relevant authority. In respect of the provisions of Ind AS 37, the disclosures required have not been provided pursuant to the limited exemption provided under paragraph 92 of Ind AS 37.
#During the year ended March 31, 2018, the Company received an order passed under section 7A of the Employees Provident Fund & Miscellaneous Provisions Act, 1952 from Employees Provident Fund Organisation (EPFO) claiming provident fund contribution aggregating to I 250 for dues up to June 2016, and excludes any additional interest that may be determined by the authorities from that date till resolution of the dispute, on (a) full salary paid to International Workers and (b) special allowance paid to employees. Based on a legal advice obtained, the Company has assessed that it has a legitimate ground for appeal, and has contested the order by filing an appeal with the Employees' Provident Funds Appellate Tribunal. In view of the changes in the regulations with the new wage code and social security code, the Company, supported by legal advice, continues to re-estimate the probability of any liability arising from this matter and has accordingly recognized a provision of I 905 (As at March 31, 2025: I 856), including estimated interest, as on the date of the balance sheet.
(I) Performance obligations and remaining performance obligations:
The remaining performance obligation disclosure provides the aggregate amount of the transaction price yet to be recognized as at the end of the reporting year and an explanation as to when the Company expects to recognize these amounts in revenue. Applying the practical expedient as given in Ind AS 115, the Company has not disclosed the remaining performance obligation related disclosures for contracts where the revenue recognized is on time and material basis. Remaining performance obligation estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustment for revenue that has not materialized and adjustments for currency.
The aggregate value of performance obligations that are completely or partially unsatisfied as at March 31,2026, other than those meeting the exclusion criteria mentioned above, is I 394,504 (As at March 31,2025: I 293,181). Out of this, the Company expects to recognize revenue of around 55% (For the year ended March 31,2025: 62%) within the next one year and the remaining thereafter.
1. Includes net gain of I 5,075 on sale of investments (For the year ended March 31,2025: I 2,443)
2. The Company hedges its operational business exposure on a net basis (i.e. expected revenue in foreign currency less expected expenditure in related currency). The foreign exchange gain/(loss) reported above includes loss on derivative financial instrument which are designated as cash flow hedges of I 3,926 (For the year ended March 31, 2025: loss of I 137) and loss on fair value hedges of I 2,304 (For the year ended March 31,2025: loss of I 286).
3. Miscellaneous income includes gain from modification in leases of I 163 (For the year ended March 31, 2025: I 56)
Major matters in relation to Income Tax
The Company has received following tax demands as at March 31,2026:
1. I 3,095 including interest of I 212 as at March 31,2026 (As at March 31, 2025: demand of I 3,095 including interest of I 212), on account of disallowance of exemption u/s 10A/10AA on profits earned by STPI Units/SEZ units on onsite export revenue.
2. I 927 (As at March 31, 2025: I 927) majorly on account of disallowance of certain expenses under section 40(a)(ia) and addition to income u/s 69.
3. I 757 (As at March 31,2025: I 757) primarily on account of transfer pricing adjustments.
Major matters in relation to Indirect taxes
The Company has received tax demand of I 5,171 (As at March 31,2025: I 4,579) on account of zero rated supply and ITC disallowances for which the final adjudication is yet to be settled.
The Company believes that its position is likely to be upheld by appellate authorities and considering the facts, the ultimate outcome of these proceedings is not likely to have material adverse effect on the results of operations or the financial position.
(I) Estimated amount of contracts remaining to be executed on capital account (net of advances) and not provided for is I 4,674 (As at March 31,2025: I 6,340).
(II) Uncalled capital commitments outstanding as at March 31,2026 is I 1,058 (As at March 31,2025: I 1,999).
I) General descriptions of defined benefit plans:
i) Gratuity plan
The Company provides for gratuity, a defined benefit retirement plan (“the Gratuity Plan”) covering eligible employees of LTM Limited. The Gratuity Plan provides a lumpsum payment to vested employees at retirement, death, incapacitation or termination of employment, of an amount based on the respective employee’s salary and the tenure of employment with the Company.
The Company contributes gratuity liabilities to the LTIMindtree Employees’ Group Gratuity Assurance Scheme for employees based in India. Trustees administer contributions made to the Trusts and contributions are invested in schemes with Insurers as permitted by Indian law.
ii) Post-retirement medical benefit plan
The post-retirement medical benefit plan provides for reimbursement of health care costs to certain categories of employees post their retirement. The reimbursement is subject to an overall ceiling limit sanctioned at the time of retirement. The ceiling limits are based on cadre of the employee at the time of retirement.
iii) Provident fund plan
The Company’s provident fund plan is managed by its holding company through a Trust permitted under the Provident Fund Act, 1952. The plan envisages contribution by employer and employees of the Company and guarantees interest at the rate notified by the Provident Fund Authority. The contribution by employer and employee together with interest are payable at the time of separation from service or retirement whichever is earlier. The benefit under this plan vests immediately on rendering of service.
The interest payment obligation of trust managed provident fund is assumed to be adequately covered by the interest income on long term investments of the fund. Any shortfall in the interest income over the interest obligation is recognised immediately in the statement of profit and loss. Any loss arising out of the investment risk and actuarial risk associated with the plan is recognised as actuarial loss in the year in which such loss occurs. Further, I Nil has been provided for the year ending March 31,2026 and March 31,2025 based on actuarial valuation towards the future obligation arising out of interest rate guarantee associated with the plan.
II) Implementation of New Labour Codes
Effective November 21, 2025, the Government of India consolidated 29 existing labour regulations into four Labour codes, namely, The Code on Wages, 2019, The Industrial Relations Code, 2020, The Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes'. Based on the requirements of New Labour Codes and relevant Accounting Standards, the Company has estimated the liability for employee benefits, which has resulted in an incremental expense on account of recognition of past service costs. Considering the material, one-time nature of the incremental amount, the Company has presented the same as an 'Exceptional Item' in the standalone statement of profit and loss for the year ended March 31,2026 amounting to I 5,281.
XII) Sensitivity analysis
i) Gratuity plan
Gratuity is a lump sum plan and the cost of providing these benefits is typically less sensitive to small changes in demographic assumptions. The key actuarial assumptions to which the benefit obligation results are particularly sensitive to are discount rate, future salary escalation rate and withdrawal rate. The following table summarizes the impact on the reported defined benefit obligation at the end of the reporting year arising on account of an increase or decrease in the reported assumption as below:
ii) Post retirement benefits:
Although the obligation of the Company under the post-retirement medical benefit plan is limited to the overall ceiling limits, assumed healthcare cost trend rates may affect the amounts recognised in the statement of profit and loss. The benefit obligation results for the cost of paying future hospitalization premiums to insurance company and reimbursement of domiciliary medical expenses in future for the employee/beneficiaries during their lifetime is sensitive to discount rate, future increase in healthcare costs and longevity. The following table summarizes the impact on the reported defined benefit obligation at the end of the reporting year arising on account of changes in these four key parameters:
II) Fair value hierarchy:
Level 1- Quoted prices (unadjusted) in the active markets for identical assets or liabilities.
Level 2- Inputs other than quoted prices included with in level 1 that are observable for assets or liabilities, either directly (i.e. as prices) or indirectly (i.e. derived from prices).
Level 3- Inputs for assets or liabilities that are not based on observable market data (unobservable inputs).
The following table presents the fair value measurement hierarchy of financial assets and liabilities measured at fair value on recurring basis as at March 31,2026 and March 31,2025.
1% change in the unobservable inputs used in fair valuation of Level 3 assets and liabilities does not have a significant impact on the value.
The following methods and assumptions were used to estimate the fair values of level 2 and level 3 financial instruments included in the above table:
i) The fair values of the unquoted equity, preference shares and convertible instruments have been estimated using an appropriate valuation model (Discounted cash flow model, Option pricing model, etc). The valuation requires management to make certain assumptions about the model inputs, including forecast cash flows, discount rate, credit risk and volatility/ the probabilities of the various estimates within the range can be reasonably assessed and are used in management's estimate of fair value for these unquoted investments.
ii) Mark to market on forward covers and embedded derivative instruments is based on forward exchange rates at the end of reporting year and discounted using G-sec rate plus applicable spread.
III) Financial risk management
The Company's activities expose it to a variety of financial risks - currency risk, interest rate risk, credit risk and liquidity risk. The Company’s primary focus is to foresee the unpredictability of financial markets and seek to minimize the potential adverse effects on its financial performance.
Market risk
Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Such changes in the values of financial instruments may result from changes in the foreign currency exchange rates, interest rates, credit, liquidity and other market changes. The Company’s exposure to market risk is primarily on account of foreign currency exchange rate risk. The Company uses derivative financial instruments to mitigate the risks arising out of foreign exchange related exposures. The Company's exposure to credit risk is influenced mainly by the individual characteristic of each customer and the concentration of risk from the top few customers. The Board of Directors reviews and agrees policies for managing each of these risks, which are summarised below:
a) Currency risk
The Company operates in multiple geographies and contracts in currencies other than the domestic currency exposing it to risks arising from fluctuation in the foreign exchange rates. The Company uses derivative financial instruments to mitigate foreign exchange related exposures. All derivative activities for risk management purposes are carried out by specialist teams that have the appropriate skills, experience and supervision. It is the Company's policy that no trading in derivative for speculative purposes may be undertaken.
The Company's revenues are principally in foreign currencies and the maximum exposure is in US dollars.
The Board of Directors of the Company has approved the financial risk management policy covering management of foreign currency exposures. The treasury department monitors the foreign currency exposures and enters into appropriate hedging instruments to mitigate its risk. The Company hedges its exposure on a net basis (i.e. expected revenue in foreign currency less expected expenditure in related currency). Consequently, the Company uses derivative financial instruments, such as foreign exchange forward contracts and option contracts, designated as cash flow hedges and fair value hedges to mitigate the risk of changes in foreign currency exchange rates in respect of its forecasted cash flows and on balance sheet exposures.
The details in respect of the outstanding foreign exchange forward contracts and option contracts are given under the derivative financial instruments section below.
In respect of the Company’s derivative financial instruments, a 1% decrease/increase in the respective exchange rates of each of the currencies underlying such contracts would have resulted in:
a) an approximately I401 increase and I401 decrease in the Company’s net profit in respect of its fair value hedges and I 3,446 increase and I 3,446 decrease in the Company’s effective portion of cash flow hedges as at March 31, 2026
b) an approximately I222 increase and I222 decrease in the Company’s net profit in respect of its fair value hedges and I 3,198 increase and I 3,198 decrease in the Company’s effective portion of cash flow hedges as at March 31, 2025
The following table presents foreign currency risk from non-derivative financial instruments as at March 31,2026:
As at March 31, 2026, every 1% increase/decrease in the respective foreign currencies compared to functional currency of the Company would result in increase/decrease in the Company’s profit before taxes for the year by approximately 1.06% and (1.06)% respectively.
As at March 31, 2025, every 1% increase/decrease in the respective foreign currencies compared to functional currency of the Company would result in increase/decrease in the Company’s profit before taxes for the year by approximately 1.10% and (1.10)% respectively.
Derivative Financial Instruments
The Company is exposed to foreign currency fluctuations on foreign currency assets/liabilities and certain Highly Probable Forecast Exposures (HPFE) denominated in foreign currency. The Company follows established risk management policies, including the use of derivatives to hedge foreign currency assets/liabilities and HPFE. The Company regularly reviews its foreign exchange forward and option positions both on a standalone basis and in conjunction with its underlying foreign currency related exposures. The Company monitors the potential risk arising out of the market factors like exchange rates on a regular basis. The counterparty in these derivative instruments is a bank and the Company considers the risks of non-performance by the counterparty as non-material. The Company has considered the effect of changes, if any, in both counterparty credit risk and its own credit risk in assessing hedge effectiveness and measuring hedge ineffectiveness.
(ii) The foreign exchange forward and option contracts designated as cash flow hedges mature over a maximum period of 60 months. The Company manages its exposures normally for a period of up to 5 years based on the estimated exposure over that period.
The table below analyses the derivative financial instrument into relevant maturity based on the remaining period as of the balance sheet date. Contracts with maturity not later than twelve months include certain contracts which can be rolled over to subsequent periods in line with underlying exposures.
b) Interest risk
Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company has no interest rate risk with respect to borrowings as at March 31, 2026 and March 31,2025.
c) Credit risk
Credit risk refers to the risk of default on its obligation by a counterparty resulting in a financial loss. The carrying amount of all financial assets represents the maximum credit exposure. The maximum exposure to credit risk was I 244,634 and I 208,888 as at March 31,2026 and March 31,2025 respectively being the total of the carrying amount of investments, trade receivables, unbilled revenue, cash and other bank balances and all other financial assets.
The principal credit risk that the Company exposed to is non-collection of trade receivable and late collection of receivable and on unbilled revenue leading to credit loss. The risk is mitigated by reviewing creditworthiness of the prospective customers prior to entering into contract and post contracting, through continuous monitoring of collections by a dedicated team.
The Company makes adequate provision for non-collection of trade receivable and unbilled receivables. Further, the Company has not suffered significant payment defaults by its customers. The Company has considered the latest available credit-ratings of customers to ensure the adequacy of allowance for expected credit loss towards trade and other receivables.
In addition, for delay in collection of receivable, the Company has made a provision for Expected Credit loss (‘ECL’) based on an ageing analysis of its trade receivable and unbilled revenue. The Company has used a practical expedient by computing the expected credit loss allowance for trade receivables and unbilled revenue based on a provision matrix. The provision matrix takes into account historical credit loss experience and adjusted for forward¬ looking information.
The Company's exposure to credit risk is influenced mainly by the individual characteristic of each customer and the concentration of risk from the top few customers. Exposure to customers is diversified and the percentage of revenue from its top five customers is 25.5% for the year ended March 31,2026 (For the year ended March 31,2025: 29%). No customer accounted for more than 10% of the trade receivables as at March 31,2026 and March 31,2025.
ECL allowance for non-collection and delay in collection of receivable and unbilled revenue, on a combined basis was I 2,648 and I 2,415 as at March 31,2026 and March 31, 2025 respectively. The movement in allowance for expected credit loss comprising provision for both non-collection and delay in collections of receivable and unbilled revenue is as follows:
(iii) During the year ended March 31, 2026 and year ended March 31,2025, the Company has designated certain foreign exchange forward and options contracts as cash flow hedges to mitigate the risk of foreign exchange exposure on highly probable forecast cash transactions. The related hedge transactions which form part of hedge reserve as at March 31,2026 and March 31,2025 will occur and be reclassified to the statement of profit and loss over a period of 60 months. For reconciliation of cash flow hedge reserve, refer note 19 (VII).
Actual future gains and losses associated with forward contracts designated as cash flow hedge may differ materially from the sensitivity analysis performed as of March 31,2026 and March 31,2025 due to the inherent limitations associated with predicting the timing and amount of changes in foreign currency exchange rates and the Company’s actual exposures and position.
The Company is also exposed to counter-party risk in relation to financial instruments taken to hedge its foreign currency risks. The counter-parties are banks and the Company has entered into contracts with the counter-parties for all its hedge instruments and in addition, entered into suitable credit support agreements to limit counter party risk where necessary.
The Company’s investments primarily include investment in mutual fund units, bonds, commercial papers, government securities, InvITs and REITs and deposits with banks and financial institutions. The Company mitigates the risk of counter-party failure by investing in mutual fund schemes with large assets under management, investing in debt instruments issued with sound credit rating and placing corporate deposits with banks and financial institutions with high credit ratings assigned by domestic and international credit rating agencies. The Company does not expect any losses from non-performance by these counterparties, and does not have any significant concentration of exposures to specific industry sectors.
Credit risk on cash and cash equivalents is limited as the Company generally invest in deposits with banks and financial institutions with high ratings assigned by international and domestic credit rating agencies and analyzing market information on a continuous and evolving basis. Ratings are monitored periodically and the Company has considered the latest available credit ratings as well any other market information which may be relevant at the date of approval of these financial statements.
d) Liquidity risk
Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company’s treasury department is responsible for liquidity, funding, investment as well as settlement management. Surplus funds are invested in non-speculative financial instruments that include highly liquid funds and corporate deposits. Also, the Company has unutilized credit limits with banks.
The Company’s policy is to maintain a strong capital base so as to maintain investor, creditor and market confidence and to sustain future development of the business. The Company monitors the return on capital as well as the level of dividends on its equity shares. The Company’s objective when managing capital is to maintain an optimal structure so as to maximize shareholder value.
(I) Terms and Conditions:
The Company participates in a supplier financing arrangement (SFA). Under the arrangement, a financial institution agrees to pay amounts to a participating suppliers in respect of invoices owed by the Company and receives settlement from the Company at a later date. The principal purpose of the arrangement is to facilitate early payment to vendors, efficient payment processing and enable the company to pay over the period of time to manage its working capital. The term of agreement varies from 12 to 36 months. No guarantees or collateral are provided under the arrangement.
Amount required to be spent by the Company on Corporate Social Responsibility (CSR) related activities during the year ended March 31, 2026 is I 957 (For the year ended March 31, 2025: I 928) and actual spent is I 960, including a provision of I 8 (For the year ended March 31,2025: I 928, including a provision amount of I 44 for unspent CSR). The CSR initiatives are primarily in relation to major thrust areas of Education, Health and Wellness, Livelihood, Environment, Women Empowerment, and upliftment of Persons with Disabilities.
*Represents donations made to fund CSR spends (including transfers from Escrow account for unspent liabilities of previous years) and other operating expense.
Note:
During the year ended March 31, 2025, a provision of I 44 was created for unspent CSR expenses, which has been utilised during the year ended March 31, 2026.
During the year ended March 31,2022 a provision of I 77 was created for unspent CSR expenses, of which I 3 has been utilized during the year ended March 31,2025, I 39 and I 35 during the year ended March 31, 2024 and March 31,2023 respectively.
Dividends paid during the year ended March 31,2026 include an amount of I 45 per equity share towards final dividend for the year ended March 31,2025 and an amount of I 22 per equity share towards interim dividend. Dividends paid during the year ended March 31,2025 include an amount of I 45 per equity share towards final dividend for the year ended March 31,2024 and an amount of I 20 per equity share towards interim dividend. Dividends declared by the Company are based on profits available for distribution.
On April 23, 2026, the Board of Directors of the Company have recommended a final dividend of I 53 per share in respect of the year ended March 31,2026 subject to the approval of shareholders at the Annual General Meeting, and if approved, would result in a cash outflow of approximately I 15,712.
Note 50 The Company has transferred I 4 to Investor Education and Protection Fund during the year ended March 31,2026.
Note 51 Figures mentioned as ‘0’ in the financial statements denotes figures less than I 0.5 million.
Note 52 Previous year’s figures have been regrouped wherever applicable to facilitate comparability.
Note 53 The financial statements were approved by the Board of Directors on April 23, 2026.
|